RIVOTRIL

This brand name is authorized in Australia, Austria, Brazil, Canada, Croatia, Ecuador, Estonia, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Romania, South Africa, Spain, Turkey.

Active ingredients

The drug RIVOTRIL contains one active pharmaceutical ingredient (API):

1	Clonazepam UNII 5PE9FDE8GB - CLONAZEPAM
	Clonazepam exhibits pharmacological properties which are common to benzodiazepines and include anticonvulsive, sedative, muscle relaxing and anxiolytic effects. Animal data and electroencephalographic investigations in man have shown that clonazepam rapidly suppresses many types of paroxysmal activity including the spike and wave discharge in absence seizures (petit mal), slow spike wave, generalised spike wave, spikes with temporal or other locations as well as irregular spikes and waves.
	Read more about Clonazepam

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
RIVOTRIL Concentrate for solution for injection / infusion	MPI, EU: SmPC	Health Products Regulatory Authority (IE)
RIVOTRIL Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N03AE01	Clonazepam	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AE Benzodiazepine derivatives
Discover more medicines within N03AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11520H, 11559J, 12534Q, 1807D, 1808E, 3478C, 5339B
BR	Câmara de Regulação do Mercado de Medicamentos	529204801117315, 529204802113313, 529204803136317, 529204804116311, 529204805112318, 529204807115314
CA	Health Products and Food Branch	00382825, 00382841
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	29363-1-09-10, 29364-1-09-10
EE	Ravimiamet	1004544, 1103791, 1764479, 1767281
ES	Centro de información online de medicamentos de la AEMPS	52332, 52333, 52334, 52401
FR	Base de données publique des médicaments	61496251, 63523836, 68429141
HK	Department of Health Drug Office	57397, 57404
HR	Agencija za lijekove i medicinske proizvode	HR-H-208455414, HR-H-410362498
IE	Health Products Regulatory Authority	64742
IL	מִשְׂרַד הַבְּרִיאוּת	339
JP	医薬品医療機器総合機構	1139003C1044, 1139003C2040, 1139003F1040, 1139003F2047, 1139003F3043
LT	Valstybinė vaistų kontrolės tarnyba	1003918
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	81988, 82115
NL	Z-Index G-Standaard	12145246, 12145254
NL	Z-Index G-Standaard, PRK	2984, 7102, 7110, 7129
NZ	Medicines and Medical Devices Safety Authority	1851, 1852
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68923001, W68924001
TR	İlaç ve Tıbbi Cihaz Kurumu	8699525094889, 8699525594877, 8699525754868
ZA	Health Products Regulatory Authority	F/2.5/187, F/2.5/190